Buscar
Mostrando ítems 1-10 de 148
Effectiveness of Meningococcal C conjugate vaccine in Salvador, Brazil: a case-control study.
(Public Library of Science, 2015-04)
Effectiveness of Meningococcal C conjugate vaccine in Salvador, Brazil: a case-control study.
(Public Library of ScienceBrasil, 2015-04)
During a citywide epidemic of serogroup C meningococcal disease in Salvador in 2010,
Brazil, the state government initiated mass vaccination targeting two age groups with high attack rates: individuals aged <5 years and ...
Cost-effectiveness analysis of a multicomponent meningococcal serogroup B vaccine in hypothetic epidemic situation in a middle-income country
(Taylor and Francis Inc., 2015)
© 2015 Taylor & Francis Group, LLC. NmenB vaccine (4CMenB) is now available, but studies on the cost-effectiveness of vaccine introduction in a country outbreak situation are lacking. The aim of this study was to evaluate ...
Meningococcal invasive disease caused by serogroup B in two chilean children vaccinated against ACWY serogroups Enfermedad meningocóccica invasora por serogrupo B en dos niños chilenos vacunados contra serogrupos ACWY
(Sociedad Chilena de Infectologia, 2016)
© 2016, Sociedad Chilena de Infectologia. All rights reserved. Invasive meningococcal disease (IMD) by serogroup W has become predominant in Chile since 2012, prompting vaccination with conjugate ACWY. We reported two ...
Enfermedad meningocóccica invasora por serogrupo B en dos niños chilenos vacunados contra serogrupos ACWY
(Sociedad Chilena de Infectología, 2016-12)
Invasive meningococcal disease (EVID) by serogroup W has become predominant in Chile since 2012, prompting vaccination with conjugate ACWY. We reported two pediatric cases in patients already vaccinated, which evolved with ...
The current situation of meningococcal disease in Latin America and updated Global Meningococcal Initiative (GMI) recommendations
(Elsevier, 2015)
The Global Meningococcal Initiative (GMI) was established in 2009 and comprises an international team of scientists, clinicians, and public health officials with expertise in meningococcal disease (MD). Its primary goal ...
Proposal of an intranasal formulation for meningococcal group C conjugate vaccine
(Fiocruz/Instituto de Tecnologia em Imunobiológicos, 2018)
Avaliação da combinação das vacinas brasileiras contra Neisseria meningitidis sorogrupos B e C
(Fiocruz/Instituto de Tecnologia em Imunobiológicos, 2018)